FDA Approves Covid-19 Booster for 5-11 Year Olds

On Tuesday, the FDA announced that children aged 5-11 could receive the Pfizer BioNTech Covid-19 booster. The booster can be given five months after they’ve received the first two primary doses.

The booster shot is 10 micrograms, which is the same amount as the primary dose in the series. It’s a third of the amount of the adult dose intended for those 12 and older. 

The decision will now move to the Centers for Disease Control and Prevention to recommend how the boosters should be used for this age group. The CDC Director, Rochelle Walensky, is expected to make a final recommendation on Thursday after an advisory committee meeting. If approved, the shots could be rolled out on Friday. 

A vaccine expert at Children’s Hospital of Philadelphia stated, “The booster dose should provide better protection against mild illness caused by omicron and its family of subvariants, which appear to be more adept than previous strains at sidestepping immunity from vaccinations or prior infection.”

He noted the third dose provides three to six months of better protection. The first two doses were not very good against the Omicron variant. 

Join The Discussion

Related Posts